SLXP
T. Rowe Price Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-156,273
| Closed | -$27M | – | 2607 |
|
|
2015
Q1 | $27M | Sell |
156,273
-758,600
| -83% | -$131M | 0.01% | 1034 |
|
|
2014
Q4 | $105M | Buy |
914,873
+680,400
| +290% | +$78.2M | 0.02% | 606 |
|
|
2014
Q3 | $36.6M | Buy |
234,473
+57,600
| +33% | +$9M | 0.01% | 934 |
|
|
2014
Q2 | $21.8M | Buy |
176,873
+13,900
| +9% | +$1.71M | ﹤0.01% | 1103 |
|
|
2014
Q1 | $16.9M | Buy |
162,973
+2,600
| +2% | +$269K | ﹤0.01% | 1162 |
|
|
2013
Q4 | $14.4M | Sell |
160,373
-315,500
| -66% | -$28.4M | ﹤0.01% | 1186 |
|
|
2013
Q3 | $31.8M | Buy |
475,873
+4,600
| +1% | +$308K | 0.01% | 960 |
|
|
2013
Q2 | $31.2M | Buy |
+471,273
| New | +$31.2M | 0.01% | 942 |
|